MG-132是一种蛋白酶体(proteasome) 抑制剂,IC50为100 nM,也抑制钙蛋白酶,IC50为1.2 μM。MG132可以抑制NLRP1的活化。
别名:Z-Leu-Leu-Leu-al; MG-132
MG-132是一种蛋白酶体抑制剂,IC50为100 nM,也抑制钙蛋白酶,IC50为1.2 μM。MG132通过诱导细胞周期停滞以及引发细胞凋亡来抑制HeLa细胞的生长。MG-132 (10 μM) 通过抑制蛋白酶体介导的IκBα降解,有效抑制A549细胞中TNF-α诱导的NF-κB活化。MG132可以抑制NLRP1的活化。
体内研究中,MG-132(ip,0.1 mg/kg/day)通过调节ERK1/2和JNK1信号通路,减轻压力超负荷引起的心脏肥大。MG-132治疗通过下调肌肉特异性泛素连接酶atrogin-1/MAFbx 和MuRF-1 mRNA,显著减少小鼠体内固定化诱导的骨骼肌萎缩。
Adv Sci (Weinh). 2024 Jan;e2207435.
Environ Int. 2024 Sep;191:108975.
Int J Biol Macromol. 2024 Oct 30.
Plant Physiol. 2024 Jan ;10:kiae011..
Transcription factor PbNAC71 regulates xylem and vessel development to control plant height
Vet Microbiol. 2024 Jun 6;295:110150.
JEV infection leads to dysfunction of lysosome by downregulating the expression of LAMP1 and LAMP2
biorxiv. 2024 Mar 25;14(7):999.
LncRNA-Snhg3 Aggravates Hepatic Steatosis by Regulating PPARγ SND1/H3K27me3
bioRxiv. 2024 Aug 10.
LncRNA Snhg3 Aggravates Hepatic Steatosis via PPARgamma Signaling
J Inflamm Res. 2023 Feb 27;16:861-877.
Cell Death Differ. 2023 Oct;30(10):2213-2230.
Cancer Lett. 2023 Jul 28;567:216262.
J Transl Med. 2023 May 5;21(1):303.
Plant Physiol. 2023 Feb 12;191(2):1052-1065.
BMC Biol. 2023 Apr 7;21(1):75.
1, 6-Hexanediol regulates angiogenesis via suppression of cyclin A1-mediated endothelial function
Cell Death Discov. 2023 Apr 26.
FASEB J. 2023 May;37(5):e22931.
The novel peptide PFAP1 promotes primordial follicle activation by binding to MCM5
World J Gastroenterol. 2023 Sep 21;29(35): 5104-5124.
Cell Death Differ. 2022 Jul;29(7):1395-1408.
SARS-CoV-2 membrane protein causes the mitochondrial apoptosis and pulmonary edema via targeting BOK
Ecotoxicol Environ Saf. 2022 Jun 1;237:113564.
Virol Sin. 2022 Aug 16;S1995-820X(22)00143-2.
Cell Biol Toxicol. 2022 Apr;38(2):291-310.
Bioengineered. 2022 Apr;13(4):8000-8012.
J Cell Mol Med. 2022 May;26(9):2646-2657.
Exp Ther Med. 2022 Sep 23;24(5):687.
MG132 protects against lung injury following brain death in rats
Adv Sci (Weinh). 2021 Jan 6;8(4):2003205.
Cell Death Dis. 2021 Aug 21;12(9):803.
USP14 maintains HIF1-α stabilization via its deubiquitination activity in hepatocellular carcinoma
Cell Death Dis. 2021 Oct 16;12(11):955.
Essential role of zyxin in platelet biogenesis and glycoprotein Ib-IX surface expression
PLoS Pathog. 2021 Feb;17(2):e100899.
Int J Mol Sci. 2021 Aug 16;22(16):8779.
Autophagy Mediates the Degradation of Plant ESCRT Component FREE1 in Response to Iron Deficiency
J Cancer. 2021 Oct 17;12(23):7041-7051.
N6-methyladenosine regulates ATM expression and downstream signaling
Oncogene. 2020 Apr;39(15):3163-3178.
The EGFR-ZNF263 Signaling Axis Silences SIX3 in Glioblastoma Epigenetically
Mol Ther Nucleic Acids. 2020 Mar 6;19:1198-1208.
lncRNA RMST Suppressed GBM Cell Mitophagy through Enhancing FUS SUMOylation
Mol Ther Nucleic Acids. 2020 Mar 6;19:1198-1208.
lncRNA RMST Suppressed GBM Cell Mitophagy through Enhancing FUS SUMOylation.
Aging (Albany NY). 2020 Jul 17;12(14):14699-14717.
Acetylation-mediated degradation of HSD17B4 regulates the progression of prostate cancer
Cell Microbiol. 2020 Mar;22(3):e13148.
Hepatitis B virus X protein modulates upregulation of DHX9 to promote viral DNA replication.
Front Cell Infect Microbiol. 2020 Apr 16;10:158.
Curr Biol. 2018 Aug 20;28(16):2616-2623.e5.
Chloroplast Biogenesis Controlled by DELLA-TOC159 Interaction in Early Plant Development.
Oncotarget. 2018 Feb;9(12):10470-10482.
Autophagy. 2017 Mar 4;13(3):538-553.
Acetylation targets HSD17B4 for degradation via the CMA pathway in response to estrone
J Hematol Oncol. 2017 Jun 8;10(1):115.
体外实验* | |
---|---|
细胞系 | Lung cancer cell lines A549 and H1299 |
方法 | Cell viability assay. Cell viability was determined using the 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay. Cells were seeded in 96-well plates at a density of 2.5x103/well 1 day prior to treatment. Then, cells were treated with MG132 or/and irradiation. After treatment, 20 µl of 5 mg/ml MTT solution was added into each well and incubated for 4 h. After the supernatant was removed, 100 µl of DMSO was added, and then placed in a microplate reader to measure OD value. Cell viability rate (vR) was calculated according to the following formula: vR = (OD in observed group/OD in 0 Gy group) x 100%. All assays were repeated 3 times in quintuplicate. |
浓度 | 200 nM |
处理时间 | 6h |
*上述方法来自公开文献,仅供相同目的实验参考。如实验目的、材料、方法不同,请参考其他文献。
体内实验* | |
---|---|
动物模型 | Male mdx (C57BL/10ScSn DMD mdx) mice |
配制 | Dissolved in DMSO, and diluted in PBS |
剂量 | ~10 μg/kg/day |
给药处理 | Injection |
*上述方法来自公开文献,仅供相同目的实验参考。如实验目的、材料、方法不同,请参考其他文献。
分子量 | 475.62 |
分子式 | C26H41N3O5 |
CAS号 | 133407-82-6 |
溶解性(25°C) | DMSO 80 mg/mL Ethanol 20 mg/mL |
储存条件 |
粉末型式 -20°C 3年;4°C 2年 溶于溶剂 -80°C 6个月;-20°C 1个月 |
运输方式 | 冰袋运输,根据产品的不同,可能会有相应调整。 |
*下述溶液配置方法仅为基于分子量计算出的理论值。不同产品在配置溶液前,需考虑其在不同溶剂中的溶解度限制。
Concentration / Solvent Volume / Mass | 1 mg | 5 mg | 10 mg |
---|---|---|---|
1 mM | 2.1025 mL | 10.5126 mL | 21.0252 mL |
5 mM | 0.4205 mL | 2.1025 mL | 4.205 mL |
10 mM | 0.2103 mL | 1.0513 mL | 2.1025 mL |
小鼠 | 大鼠 | 兔 | 豚鼠 | 仓鼠 | 狗 | |
重量 (kg) | 0.02 | 0.15 | 1.8 | 0.4 | 0.08 | 10 |
体表面积 (m2) | 0.007 | 0.025 | 0.15 | 0.05 | 0.02 | 0.5 |
Km 系数 | 3 | 6 | 12 | 8 | 5 | 20 |
动物 A (mg/kg) = 动物 B (mg/kg) × | 动物 B的Km系数 |
动物 A的Km系数 |
例如,依据体表面积折算法,将化合物用于小鼠的剂量20 mg/kg 换算成大鼠的剂量,需要将20 mg/kg 乘以小鼠的Km系数(3),再除以大鼠的Km系数(6),得到化合物用于大鼠的等效剂量为10 mg/kg。
[2] Ashley J Chui, et al. Science. N-terminal degradation activates the NLRP1B inflammasome
其他相关的Proteasome产品 |
---|
Proteasome inhibitor IX
Proteasome inhibitor IX (PS-IX; AM114) 是一种 20S 蛋白酶体 (20S proteasome) 的胰凝乳蛋白酶样活性抑制剂,IC50 值约为 1 μM。Proteasome inhibitor IX 具有 HCT116 p53+/+ 细胞生长抑制活性,IC50 值为 1.49 μM。 |
NIC-0102
NIC-0102是一种口服有效的蛋白酶体 (proteasome) 抑制剂 (pIC50=7.55),能特异性地抑制 NLRP3 炎症小体激活。NIC-0102 在体内对 DSS 诱导的溃疡性结肠炎模型显示出有效的抗炎作用。此外,NIC-0102还能抑制pro-IL-1β 的产生。 |
Ac-WLA-AMC
Ac-WLA-AMC 是一种特异性的 20S 蛋白酶体 β5 亚基荧光底物。 |
Ac-Nle-Pro-Nle-Asp-AMC
Ac-Nle-Pro-Nle-Asp-AMC 是 26S 蛋白酶体 (26S proteasome) 的特异性底物。 |
PR-39
PR-39 是富含脯氨酸和精氨酸的天然抗菌肽,是一种非竞争性,可逆和变构的蛋白酶体 (proteasome) 抑制剂。 |
产品仅供科学研究或药证申报的用途使用,不为任何个人或者非科研性质的其他用途提供服务。
Copyright © 2010-2022 AbMole版权所有 沪ICP备16047849号 沪公网安备 31011502012228号